160 related articles for article (PubMed ID: 2718386)
1. Sialic acid is cleaved from glycoconjugates at the cell surface when influenza virus neuraminidases are expressed from recombinant vaccinia viruses.
Els MC; Laver WG; Air GM
Virology; 1989 May; 170(1):346-51. PubMed ID: 2718386
[TBL] [Abstract][Full Text] [Related]
2. Transfer of the hemagglutinin activity of influenza virus neuraminidase subtype N9 into an N2 neuraminidase background.
Nuss JM; Air GM
Virology; 1991 Aug; 183(2):496-504. PubMed ID: 1853557
[TBL] [Abstract][Full Text] [Related]
3. [Expression and mutagenesis of genes coding for protein synthesis in the influenza virus].
Air GM; Lentz MR; Ritchie LR; Vai K; Hamilton AM
Vopr Virusol; 1987; 32(1):44-51. PubMed ID: 3033905
[TBL] [Abstract][Full Text] [Related]
4. Determination of viral neuraminidase specificity for membrane-bound sialic acids by cell electrophoresis.
Gimsa U; Gimsa J
Mol Membr Biol; 1997; 14(2):87-90. PubMed ID: 9253768
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus.
Baker AT; Varghese JN; Laver WG; Air GM; Colman PM
Proteins; 1987; 2(2):111-7. PubMed ID: 3447170
[TBL] [Abstract][Full Text] [Related]
6. Specificity of neuraminidase activity from influenza viruses isolated in different hosts tested with novel substrates.
Katinger D; Mochalova L; Chinarev A; Bovin N; Romanova J
Arch Virol; 2004 Nov; 149(11):2131-40. PubMed ID: 15503202
[TBL] [Abstract][Full Text] [Related]
7. Immunobiological properties of influenza A (H7N9) hemagglutinin and neuraminidase proteins.
Jiang L; Changsom D; Lerdsamran H; Wiriyarat W; Masamae W; Noisumdaeng P; Jongkaewwattana A; Puthavathana P
Arch Virol; 2016 Oct; 161(10):2693-704. PubMed ID: 27406044
[TBL] [Abstract][Full Text] [Related]
8. Structures of aromatic inhibitors of influenza virus neuraminidase.
Jedrzejas MJ; Singh S; Brouillette WJ; Laver WG; Air GM; Luo M
Biochemistry; 1995 Mar; 34(10):3144-51. PubMed ID: 7880809
[TBL] [Abstract][Full Text] [Related]
9. Mutation of the Second Sialic Acid-Binding Site, Resulting in Reduced Neuraminidase Activity, Preceded the Emergence of H7N9 Influenza A Virus.
Dai M; McBride R; Dortmans JCFM; Peng W; Bakkers MJG; de Groot RJ; van Kuppeveld FJM; Paulson JC; de Vries E; de Haan CAM
J Virol; 2017 May; 91(9):. PubMed ID: 28202753
[TBL] [Abstract][Full Text] [Related]
10. [Molecular mechanism of the variation of influenza virus hemagglutinin and neuraminidase, and their recognition of sialylglycoconjugates].
Suzuki Y
Tanpakushitsu Kakusan Koso; 1988 Feb; 33(2):117-35. PubMed ID: 3293122
[No Abstract] [Full Text] [Related]
11. Sialic acid is incorporated into influenza hemagglutinin glycoproteins in the absence of viral neuraminidase.
Basak S; Tomana M; Compans RW
Virus Res; 1985 Feb; 2(1):61-8. PubMed ID: 3984493
[TBL] [Abstract][Full Text] [Related]
12. Structure of influenza virus neuraminidase B/Lee/40 complexed with sialic acid and a dehydro analog at 1.8-A resolution: implications for the catalytic mechanism.
Janakiraman MN; White CL; Laver WG; Air GM; Luo M
Biochemistry; 1994 Jul; 33(27):8172-9. PubMed ID: 8031750
[TBL] [Abstract][Full Text] [Related]
13. Hemagglutinin specificity and neuraminidase coding capacity of neuraminidase-deficient influenza viruses.
Yang P; Bansal A; Liu C; Air GM
Virology; 1997 Mar; 229(1):155-65. PubMed ID: 9123857
[TBL] [Abstract][Full Text] [Related]
14. Red cells bound to influenza virus N9 neuraminidase are not released by the N9 neuraminidase activity.
Air GM; Laver WG
Virology; 1995 Aug; 211(1):278-84. PubMed ID: 7645221
[TBL] [Abstract][Full Text] [Related]
15. Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility.
Yen HL; Herlocher LM; Hoffmann E; Matrosovich MN; Monto AS; Webster RG; Govorkova EA
Antimicrob Agents Chemother; 2005 Oct; 49(10):4075-84. PubMed ID: 16189083
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Oligosaccharide Engineering with Alkyne Sialic Acids Confers Neuraminidase Resistance and Inhibits Influenza Reproduction.
Heise T; Büll C; Beurskens DM; Rossing E; de Jonge MI; Adema GJ; Boltje TJ; Langereis JD
Bioconjug Chem; 2017 Jul; 28(7):1811-1815. PubMed ID: 28635265
[TBL] [Abstract][Full Text] [Related]
17. The role of target membrane sialic acid residues in the fusion activity of the influenza virus: the effect of two types of ganglioside on the kinetics of membrane merging.
Ramalho-Santos J; Pedroso De Lima MC
Cell Mol Biol Lett; 2004; 9(2):337-51. PubMed ID: 15213813
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid.
Bossart-Whitaker P; Carson M; Babu YS; Smith CD; Laver WG; Air GM
J Mol Biol; 1993 Aug; 232(4):1069-83. PubMed ID: 8371267
[TBL] [Abstract][Full Text] [Related]
19. Substrate Binding by the Second Sialic Acid-Binding Site of Influenza A Virus N1 Neuraminidase Contributes to Enzymatic Activity.
Du W; Dai M; Li Z; Boons GJ; Peeters B; van Kuppeveld FJM; de Vries E; de Haan CAM
J Virol; 2018 Oct; 92(20):. PubMed ID: 30089692
[TBL] [Abstract][Full Text] [Related]
20. Postreassortment changes in influenza A virus hemagglutinin restoring HA-NA functional match.
Kaverin NV; Gambaryan AS; Bovin NV; Rudneva IA; Shilov AA; Khodova OM; Varich NL; Sinitsin BV; Makarova NV; Kropotkina EA
Virology; 1998 May; 244(2):315-21. PubMed ID: 9601502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
